Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Kyle Rove to Risk Assessment

This is a "connection" page, showing publications Kyle Rove has written about Risk Assessment.

 
Connection Strength
 
 
 
0.316
 
  1. Ha D, Halstead NV, Blanchette ED, Wilcox DT, Vemulakonda VM, Wood DN, Rove KO. Risk of acute kidney injury after lower urinary tract reconstruction with early NSAID therapy: A propensity matched retrospective analysis. J Pediatr Urol. 2024 Oct; 20(5):911-920.
    View in: PubMed
    Score: 0.117
  2. Rove KO, Warncke JC, Vemulakonda VM. Trends in pediatric urologic consultations in a tertiary care hospital setting. J Pediatr Urol. 2018 02; 14(1):12.e1-12.e8.
    View in: PubMed
    Score: 0.073
  3. Rove KO, Maroni PD, Cost CR, Fairclough DL, Giannarini G, Harris AK, Schultz KA, Cost NG. Pathologic Risk Factors for Metastatic Disease in Postpubertal Patients With Clinical Stage I Testicular Stromal Tumors. Urology. 2016 11; 97:138-144.
    View in: PubMed
    Score: 0.068
  4. Rove KO, Crawford ED, Perachino M, Morote J, Klotz L, Lange PH, Andriole GL, Matsumoto AM, Taneja SS, Eisenberger MA, Reis LO. Maximal testosterone suppression in prostate cancer--free vs total testosterone. Urology. 2014 Jun; 83(6):1217-22.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)